- Lenacapavir is an injection given twice a year.
- People can use it to help prevent HIV infection.
- Under deals the drug will cost US$40 a year.
- It will be available in 120 named countries.
- Rollout is planned from 2027 after approval.
- The Gates Foundation gives money and guarantees.
- Indian makers will make cheaper generic medicine.
- Some middle-income countries are left out of deals.
- Campaigners say more money is needed for delivery.
Difficult words
- drug — A substance used for medical treatment.
- injection — A method to give medicine using a needle.
- cost — The amount of money needed to buy something.
- infection — A disease caused by germs in the body.infections
- funding — Money that is given for a specific purpose.
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- How do you think this drug will help patients?
- What do you feel about the cost of this drug?
- Why do you think training is important for this drug?
Related articles
Gene and blood‑vessel damage add to dementia risk
Researchers studied a genetic variant (APOE ε4) and white matter hyperintensities (WMH), a sign of small blood‑vessel damage. They found both factors raise dementia risk additively, and vascular health may be improved to lower that risk.
Mpox may be spreading quietly in Nigeria
A study in Nigeria tested archived blood from healthy adults and found signs of hidden mpox exposure. Some people had old smallpox antibodies and a small number showed recent immune responses without symptoms, suggesting low-level virus circulation.
Lower mGlu5 receptor found across autistic adult brains
A study in The American Journal of Psychiatry found lower availability of a glutamate receptor called mGlu5 across the brains of autistic adults. Researchers used PET, MRI and EEG and say the result could affect future diagnosis and treatment.